(VRUS)

Loading...
Symbols:
Authors:

All Comments on VRUS

  • commenter
    SeekingAlpha
    Editors
    Apr 06 05:22 AM
    My Website
    General Discussion on VRUS
    Is this a buy or a sell? Reply
  • commenter
    paultaut
    Apr 01 05:57 PM
    Insider Buying in Biotech Land [view article]
    you watch insider buying, so do I, but they are notoriously early....

    Suggest you look at SCLN.     Reply
  • commenter
    User 142481
    Jan 21 01:19 PM
    2007 Biotech Performance Review [view article]
    If you are looking at AMAG, look at RMTI too. Like AMAG, they have a new iron therapy drug to treat anemia. Initially targeting end-stage renal disease w/ addressable market of 2M patients by 2010. They are doing another Phase II & if successful should start III in 2009. Only pure play iron play left that still cheap. Reply
  • commenter
    User 142395
    Jan 21 10:20 AM
    2007 Biotech Performance Review [view article]
    looks great Reply
  • commenter
    agosin
    Jan 10 02:50 PM
    Pharma, Biotech Present Great Investment Opportunities in 2008 [view article]
    The hidden jewel is Synta Pharm (SNTA). Only GSK has noticed.... Reply
  • commenter
    oxi_100
    Jan 09 01:36 PM
    Pharma, Biotech Present Great Investment Opportunities in 2008 [view article]
    Have anyone checked out oxigene? CEO Richard Chin have stated they will have a partner within next 6 months! It will be a deal close to what Antisoma got last year 890 milj$ or better. Check out oxigens market cap and do the math. It is a 10 bagger!

    Good Luck!     Reply

Trading Center